<unk><unk>  (HCC) most commonly appears in a patient with chronic viral hepatitis (hepatitis B or hepatitis C, 20%) or with cirrhosis (about 80%).  These patients commonly undergo surveillance with ultrasound due to the cost-effectiveness.
Hepatocellular carcinoma cost-effectiveness of therapy
Cirrhosis cost-effectiveness of therapy
Primary biliary cirrhosis future or investigational therapies
Gallstone disease cost-effectiveness of therapy
Cholangitis cost-effectiveness of therapy
Ascending cholangitis cost-effectiveness of therapy
Primary biliary cirrhosis primary prevention
Hepatology, Gallbladder, and Biliary Tract Diseases Project Chapter Priority